18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism

被引:31
作者
Pretet, Valentin [1 ]
Rotania, Marianela [1 ,2 ]
Helali, Mehdi [1 ]
Ignat, Mihaela [3 ]
Vix, Michel [3 ]
Imperiale, Alessio [1 ,4 ,5 ]
机构
[1] ICANS Univ Hosp Strasbourg, Nucl Med & Mol Imaging, F-67033 Strasbourg, France
[2] Inst Oulton, Mol & Nucl Med, X5000 JJS, Cordoba, Argentina
[3] Univ Strasbourg, IRCAD IHU, Gen Digest & Endocrine Surg, F-67033 Strasbourg, France
[4] Univ Strasbourg, Fac Med, F-67033 Strasbourg, France
[5] CNRS Unistra, IPHC, Mol Imaging DRHIM, UMR 7178, F-67033 Strasbourg, France
关键词
F-18-Fluorocholine PET; 4D contrast-enhanced CT; primary hyperparathyroidism; parathyroid; adenoma; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; COMPUTED-TOMOGRAPHY; LOCALIZATION; SCINTIGRAPHY; MANAGEMENT; SPECT/CT; SURGERY; UPDATE;
D O I
10.3390/jcm9062005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present retrospective study evaluates the diagnostic value of integrated(18)F-Fluorocholine positron emission tomography/four-dimensional contrast-enhanced computed tomography (F-18-FCH PET/4D-CT) as second-line imaging in preoperative work-up of primary hyperparathyroidism (pHPT), and compares(18)F-FCH PET with 4D-CT. Patients with pHPT and negative/discordant first-line imaging addressed for integrated(18)F-FCH PET/4D-CT were retrospectively selected. Sensitivity and detection rate (DR%) of(18)F-FCH PET/CT, 4D-CT, and PET/4D-CT were calculated according to the per patient and per lesion analyses, and afterwards compared. Histology associated with a decrease more than 50% of perioperative parathyroid hormone (PTH) blood level was used as a gold standard. Persistent high serum PTH and calcium levels during a 6-month follow-up was considered as presence of pHPT in both operated and non-operated patients. 50 patients (55 glands) were included. 44/50 patients (88%) were surgically treated. On a per patient analysis, sensitivity was 93%, 80%, and 95%, and DR% was 82%, 68%, and 84%, respectively for PET/CT, 4D-CT, and PET/4D-CT. PET/CT was more sensitive than 4D-CT (p= 0.046). PET/4D-CT performed better than 4D-CT (p= 0.013) but was equivalent to PET/CT alone. On a per gland analysis, sensitivity PET/CT, 4D-CT, and PET/4D-CT was 88%, 66%, and 92%, and DR% was 79%, 57%, and 83%, respectively. PET/CT and PET/4D-CT were more sensitive than 4D-CT alone (p= 0.01,p< 0.001, respectively). However, PET/CT and PET/4D-CT performed similarly. In conclusion,F-18-FCH PET provides better identification of hyperfunctioning parathyroids than 4D-CT and the combination of both did not significantly improve diagnostic sensitivity. Further investigations involving larger populations are necessary to define the role of(18)F-FCH PET/4D-CT as a "one-stop shop" second-line imaging in preoperative work-up of pHPT, especially considering the additional patient radiation exposure due to multi-phase CT.
引用
收藏
页数:12
相关论文
共 34 条
  • [1] [18F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level
    Alharbi, Abdullah A.
    Alshehri, Fahad M.
    Albatly, Abdulrahman A.
    Sah, Bert-Ram
    Schmid, Christoph
    Huber, Gerhard F.
    Huellner, Martin W.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2018, 20 (05) : 857 - 867
  • [2] 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients
    Amadou, Coralie
    Bera, Geraldine
    Ezziane, Malek
    Chami, Linda
    Delbot, Thierry
    Rouxel, Agnes
    Leban, Monique
    Herve, Genevieve
    Menegaux, Fabrice
    Leenhardt, Laurence
    Kas, Aurelie
    Tresallet, Christophe
    Ghander, Cecile
    Lussey-Lepoutre, Charlotte
    [J]. WORLD JOURNAL OF SURGERY, 2019, 43 (05) : 1232 - 1242
  • [3] The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism
    Araz, Mine
    Soydal, Cigdem
    Ozkan, Elgin
    Kir, Metin K.
    Ibis, Erkan
    Gullu, Sevim
    Erdogan, Murat F.
    Emral, Rifat
    Kucuk, Ozlem N.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (11) : 989 - 994
  • [4] High-resolution magic angle spinning 1H nuclear magnetic resonance spectroscopy metabolomics of hyperfunctioning parathyroid glands
    Battini, Stephanie
    Imperiale, Alessio
    Taieb, David
    Elbayed, Karim
    Cicek, Ercument
    Sebag, Frederic
    Brunaud, Laurent
    Namer, Izzie-Jacques
    [J]. SURGERY, 2016, 160 (02) : 384 - 394
  • [5] 4D?Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism
    Becker, J. L.
    Patel, V
    Johnson, K. J.
    Guerrero, M.
    Klein, R. R.
    Ranvier, G. F.
    Owen, R. P.
    Pawha, P.
    Nael, K.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2020, 41 (03) : 522 - 528
  • [6] Hyperparathyroidism
    Bilezikian, John P.
    Bandeira, Leonardo
    Khan, Aliya
    Cusano, Natalie E.
    [J]. LANCET, 2018, 391 (10116) : 168 - 178
  • [7] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    Bilezikian, John P.
    Brandi, Maria Luisa
    Eastell, Richard
    Silverberg, Shonni J.
    Udelsman, Robert
    Marcocci, Claudio
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : 3561 - 3569
  • [8] Dual-Time-Point 18F-Fluorocholine PET/CT in Parathyroid Imaging
    Broos, Wouter A. M.
    Wondergem, Maurits
    van der Zant, Friso M.
    Knol, Remco J. J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 1605 - 1610
  • [9] Calzada-Nocaudie M, 2006, ANN ENDOCRINOL-PARIS, V67, P7
  • [10] Epidemiology of Primary Hyperparathyroidism
    Clarke, Bart L.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2013, 16 (01) : 8 - 13